期刊文献+

结肠癌组织中MCL-1、NIBP表达情况及其与肿瘤进展的相关性 被引量:1

Relationship of MCL-1 and NIBP Expression in Colon Cancer Tissues with Tumor Progression
下载PDF
导出
摘要 【目的】探讨结肠癌患者结肠癌组织中髓细胞白血病基因-1(MCL-1)、NIK-IKK结合蛋白(NIBP)表达情况及其与肿瘤进展的相关性。【方法】采用免疫组化染色方法检测获取的82例结肠癌术后癌组织、对应的癌旁组织中的MCL-1蛋白、NIBP蛋白表达水平;分析不同TNM分期、肿瘤分化程度、病灶大小等病理学参数与结肠癌组织中的MCL-1蛋白、NIBP蛋白的阳性表达率的相关性。【结果】结肠癌组织的MCL-1蛋白、NIBP蛋白阳性率分别为68.29%、60.98%,均显著高于癌旁组织的26.83%、20.73%,差异均有统计学意义(P<0.05)。不同肿瘤浸润深度、不同病理学分化程度、不同TNM分期、是否发生淋巴结转移的结肠癌组织中MCL-1蛋白、NIBP蛋白阳性率组间比较,差异均有统计学意义(P<0.05)。【结论】结肠癌组织中MCL-1蛋白、NffiP蛋白表达较癌旁&织显著增高,这可能与结肠癌的进展有一定的相关性。 【Objective】To investigate relationship of the expression of myeloid leukemia gene-1(MCL-1)and NIK-IKK binding protein(NIBP)with tumor progression in colon cancer.【Methods】Immunohistochemical staining was used to detect the expression of MCL-1 protein and NIBP protein in 82 cases of postoperative colon cancer tissues and corresponding adjacent tissues.The pathological parameters such as different TNM stage,tumor differentiation degree and Iesion size were analyzed to reveal their relationship with positive expression rate of MCL-1 protein and NIBP protein.【Results】The positive rates of MCL-1 protein and NIBP protein in colon cancer tissues were 68.29%and 60.98%,respectively,which were significantly higher than those in adjacent tissues(26.83%and 20.73%,respectively).The differences were statistically significant(P<0.05).The differential expression of MCL-1 protein and NIBP protein in colon cancer tissues with different tumor invasion depths,TNM stages,pathological differentiation,and ljmiph node metastasis were statistically significant(P<0.05).【Conclusion】The expression of MCL-1 protein and NIBP protein in colon cancer tis-sues is significantly higher than that in adjacent tissues,which may be related to the progression of colon cancer.
作者 范钰晨 马月珍 李铠男 FAN Yu-chen;MA Yue-zhen;LI Kai-nan(Shandong Provincial Third Hospital,Jinan Shandong,2500319 China)
出处 《医学临床研究》 CAS 2020年第11期1678-1680,共3页 Journal of Clinical Research
关键词 结肠肿瘤/病理学 粒细胞白血病序列1蛋白 细胞支架蛋白质类 肿瘤 Colonic Neoplasms/PA Myeloid Cell Leukemia Sequence 1 Protein Cytoskeletal Proteins Neoplasms
  • 相关文献

参考文献5

二级参考文献79

  • 1Liang-LiangYu,Hong-GangYu,Jie-PingYu,He-ShengLuo,Xi-MingXu,Jun-HuaLi.Nuclear factor-kB p65 (RelA) transcription factor is constitutively activated in human colorectal carcinoma tissue[J].World Journal of Gastroenterology,2004,10(22):3255-3260. 被引量:15
  • 2Kuan-Song WANG.Enhancement of Metastatic and Invasive Capacity of Gastric Cancer Cells by Transforming Growth Factor-β1[J].Acta Biochimica et Biophysica Sinica,2006,38(3):179-186. 被引量:7
  • 3全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50.
  • 4Delbe ke D,Martin WH. PE and PET- CT for evaluation of colorectal carcinoma[J]. Semin Nuel Med, 2004, 34(3) : 209 - 223.
  • 5Esteves FP, Schuster DM, Halkar RK, et al. Gastrointestinal tractmalignancies and positron emission tomography: an overview[J]. Semin Nucl Med, 2006, 36(2):169 - 181.
  • 6Bloomston M, Bekaii Saab TS, Kosuri K, et al. Preoperative carbohydrate antigen is most predictive of malignancy in older jaundiced patients undergoing pancreatic resection[J]. Pancreas,2006,33(3) :246 - 249.
  • 7Lee IK, Kimdo H, Gorden DL, et al. Prognostic value of CEA and CA19 - 9 tumor markers combined with cytology from peritoneal fluid in coiorectal cancer [J]. Ann Surg Oncol, 2009,16(4):861 - 870.
  • 8Chen CC,Yang SH,Lin JK,et al. Is it reasonable to add preoperative serum level of CEA and CA19 - 9 to staging for colorectal cancer[J]. J Surg Res, 2005,124(2) : 169 - 174.
  • 9Morita S, Nomura T, Fukushima Y, et al. Does serum CA19 - 9 play a practical role in the management of patients with colorectal cancer[J]. Dis Colon Rectum, 2010,47 (2): 227 - 232.
  • 10Kanellos I,Zacharakis E,Kanellos D,et al. Prognostic significance of CEA levels and detection of CEA mRNA in draining venous blood in patients with colorectal cancer[J]. J Surg Oncol,2009,94(1):3 - 8.

共引文献878

同被引文献22

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部